| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vincerx Pharma Inc (NASDAQ: VINC)
VINC Technical Analysis
5
| As on 2nd Jan 2025 VINC STOCK Price closed @ 0.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.59 & Strong Sell for SHORT-TERM with Stoploss of 0.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VINCSTOCK Price
| Open | 0.23 | Change | Price | % |
| High | 0.24 | 1 Day | -0.02 | -7.41 |
| Low | 0.20 | 1 Week | 0.05 | 25.00 |
| Close | 0.25 | 1 Month | -0.06 | -19.35 |
| Volume | 5415105 | 1 Year | -0.97 | -79.51 |
| 52 Week High 8.06 | 52 Week Low 0.18 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| MBIO | 0.21 | 16.67% |
| NVDA | 138.31 | 2.99% |
| LMDX | 0.02 | 0.00% |
| TSLA | 379.28 | -6.08% |
| AKTS | 0.04 | 0.00% |
| LCID | 3.03 | 0.33% |
| CRKN | 0.14 | 0.00% |
| QSI | 4.26 | 57.78% |
| FFIE | 3.69 | 51.85% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VINC Daily Charts |
VINC Intraday Charts |
Whats New @ Bazaartrend |
VINC Free Analysis |
|
|
VINC Important Levels Intraday
| RESISTANCE | 0.33 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.29 |
| RESISTANCE | 0.27 |
| SUPPORT | 0.23 |
| SUPPORT | 0.21 |
| SUPPORT | 0.20 |
| SUPPORT | 0.17 |
VINC Forecast January 2025
| 4th UP Forecast | 1.54 |
| 3rd UP Forecast | 1.13 |
| 2nd UP Forecast | 0.87 |
| 1st UP Forecast | 0.62 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -0.37 |
| 3rd DOWN Forecast | -0.63 |
| 4th DOWN Forecast | -1.04 |
VINC Weekly Forecast
| 4th UP Forecast | 0.91 |
| 3rd UP Forecast | 0.70 |
| 2nd UP Forecast | 0.57 |
| 1st UP Forecast | 0.44 |
| 1st DOWN Forecast | 0.06 |
| 2nd DOWN Forecast | -0.07 |
| 3rd DOWN Forecast | -0.20 |
| 4th DOWN Forecast | -0.41 |
VINC Forecast2025
| 4th UP Forecast | 17.96 |
| 3rd UP Forecast | 12.28 |
| 2nd UP Forecast | 8.77 |
| 1st UP Forecast | 5.26 |
| 1st DOWN Forecast | -4.76 |
| 2nd DOWN Forecast | -8.27 |
| 3rd DOWN Forecast | -11.78 |
| 4th DOWN Forecast | -17.46 |
Vincerx Pharma Inc ( NASDAQ USA Symbol : VINC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VINC Business Profile
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in Phase I clinical trials to treat solid tumors. Its preclinical stage product candidates include VIP217 for solid tumors; VIP236 to treat multiple solid tumors; VIP943 for the treatment of leukemia and myelodysplastic syndrome; and VIP924 for treating B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California. Address: 260 Sheridan Avenue, Palo Alto, CA, United States, 94306
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service